Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 51.01% is 12% below its 5-year average of 57.64%, near the low end of its 5-year range (44.36%–96.15%).
21.30% below its 12-month average of 64.81%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 62.35%.
GROSS MARGIN
51.01%
GROSS MARGIN AVG TTM
64.81%
GROSS MARGIN AVG 3Y
60.57%
GROSS MARGIN AVG 5Y
57.64%
GROSS MARGIN AVG 10Y
59.40%
GROSS MARGIN AVG 15Y
63.49%
GROSS MARGIN AVG 20Y
73.86%
CURRENT VS TTM AVG
-21.30%
CURRENT VS 3Y AVG
-15.78%
CURRENT VS 5Y AVG
-11.50%
CURRENT VS 10Y AVG
-14.13%
CURRENT VS 15Y AVG
-19.66%
CURRENT VS 20Y AVG
-30.94%
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
+8.11%
vs the sector median at left
ANI Pharmaceuticals, Inc.
Market Cap
$1.66B
Gross Margin
51.01%
TTM Avg
64.81%
3Y Avg
60.57%
5Y Avg
57.64%
Market Cap
$1.66B
Gross Margin
66.15%
TTM Avg
69.48%
3Y Avg
67.43%
5Y Avg
67.56%
Market Cap
$1.66B
Gross Margin
53.89%
TTM Avg
45.92%
3Y Avg
-11.61%
5Y Avg
-9.29%
Market Cap
$1.71B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$1.75B
Gross Margin
12.55%
TTM Avg
11.67%
3Y Avg
11.80%
5Y Avg
12.59%
Market Cap
$1.52B
Gross Margin
57.87%
TTM Avg
56.73%
3Y Avg
61.85%
5Y Avg
-49.66%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.66B | 51.01% | 64.81% | 60.57% | 57.64% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | 66.15% | 69.48% | 67.43% | 67.56% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | 53.89% | 45.92% | -11.61% | -9.29% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 49.52% | 50.81% | 52.12% | 52.25% |
| Certara, Inc. (CERT)vs › | $1.56B | 58.33% | 60.70% | 60.53% | 60.29% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.75B | 12.55% | 11.67% | 11.80% | 12.59% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 57.87% | 56.73% | 61.85% | -49.66% |
| Innoviva, Inc. (INVA)vs › | $1.52B | 73.09% | 81.06% | 86.06% | 90.71% |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | 0.00% | 0.00% | 0.00% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 76.47% | 79.35% | 79.86% | 39.87% |
Gross Margin
51.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 62.35% |
| 2026-03-31 | 51.78% |
| 2025-12-31 | 96.15% |
| 2025-09-30 | 49.07% |
| 2025-06-30 | 64.70% |
| 2025-03-31 | 62.95% |
| 2024-12-31 | 57.87% |
| 2024-09-30 | 57.48% |
| 2024-06-30 | 58.20% |
| 2024-03-31 | 64.23% |
| 2023-12-31 | 59.42% |
| 2023-09-30 | 63.51% |
| 2023-06-30 | 63.72% |
| 2023-03-31 | 64.69% |
| 2022-12-31 | 61.45% |
| 2022-09-30 | 60.76% |
| 2022-06-30 | 52.21% |
| 2022-03-31 | 46.85% |
| 2021-12-31 | 44.36% |
| 2021-09-30 | 53.11% |
| 2021-06-30 | 54.11% |
| 2021-03-31 | 63.34% |
| 2020-12-31 | 57.14% |
| 2020-09-30 | 62.03% |
| 2020-06-30 | 57.30% |
| 2020-03-31 | 56.19% |
| 2019-12-31 | 62.90% |
| 2019-09-30 | 70.78% |
| 2019-06-30 | 71.24% |
| 2019-03-31 | 72.16% |
| 2018-12-31 | 64.75% |
| 2018-09-30 | 69.22% |
| 2018-06-30 | 64.90% |
| 2018-03-31 | 55.48% |
| 2017-12-31 | 56.76% |
| 2017-09-30 | 56.24% |
| 2017-06-30 | 52.81% |
| 2017-03-31 | 55.26% |
| 2016-12-31 | 55.75% |
| 2016-09-30 | 56.73% |
| 2016-06-30 | 62.36% |
| 2016-03-31 | 83.41% |
| 2015-12-31 | 80.37% |
| 2015-09-30 | 83.68% |
| 2015-06-30 | 83.91% |
| 2015-03-31 | 85.37% |
| 2014-12-31 | 82.54% |
| 2014-09-30 | 82.39% |
| 2014-06-30 | 68.15% |
| 2014-03-31 | 75.94% |
| 2013-12-31 | 74.52% |
| 2013-09-30 | 66.45% |
| 2013-06-30 | 65.89% |
| 2013-03-31 | -1560.23% |
| 2012-12-31 | -46.10% |
| 2012-09-30 | -2003.38% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 56.28% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 100.00% |
